PFE and JNJ Related Headlines

Go Back

Dec 6, 2016 07:05AM Trump's corporate tax holiday could spur pharma M&A
Dec 5, 2016 04:15PM UPDATE: Sanofi (SNY) Said to Explore Counterbid for Actelion Amid Johnson & Johnson (JNJ) Talks - Bloomberg
Nov 25, 2016 08:23AM Johnson & Johnson approaches Actelion about takeover deal
Oct 18, 2016 07:28AM Wall St. climbs on earnings improvement
Oct 18, 2016 06:51AM J&J shares lose ground on fears of Pfizer's answer to Remicade
Oct 17, 2016 05:14PM Pfizer to start shipping biosimilar version of J&J's Remicade in November
Aug 21, 2016 06:12PM Pfizer boosts cancer drug roster with $14 billion Medivation deal
Aug 8, 2016 11:30AM Biogen (BIIB) on Watch Amid Renewed Chatter
Aug 2, 2016 11:56AM CVS, Express Scripts 2017 Formulary Exclusion Lists Make Waves
Jul 19, 2016 06:52AM Johnson & Johnson raises 2016 forecast, shares touch record high
Jun 29, 2016 07:56AM Credit Suisse Sees $157B of FCF Through 2019 Available for M&A in Biotech/Pharma Sector
May 27, 2016 08:26PM New incentives needed to develop antibiotics to fight superbugs
May 27, 2016 11:39AM G7 told to act on antibiotics as dreaded superbug hits U.S.
May 26, 2016 05:40PM U.S. sees first case of bacteria resistant to last-resort antibiotic
May 17, 2016 09:03AM Jefferies Says Pfizer/Anacor Deal Could Re-Ignite Specialty Pharma M&A; Names Several Potential Targets
Apr 19, 2016 07:02AM J&J shares hit new high on strong drug sales, weaker dollar
Apr 14, 2016 12:07PM Leerink Highlights Top 10 Biopharma Stocks for Partnerships & Acquisitions
Apr 14, 2016 10:49AM Investors find safety in J&J shares, but run could stall
Apr 5, 2016 04:02PM FDA Approves Remicade Biosimilar, Inflectra (PFE) (JNJ_
Mar 31, 2016 12:17PM FDA Puts Out Guidance on Biosimilar Labeling
Mar 18, 2016 07:29AM Piper Jaffray Likes Pfizer (PFE) Over Johnson & Johnson (JNJ) As a Defensive Heathcare Play
Jan 26, 2016 06:51AM J&J profit beats forecasts, helped by lower taxes, cost cuts
Jan 14, 2016 08:00AM Novartis (NVS) Named Top Global Pharma Pick at Jefferies

PFE and JNJ Related Press Releases

Go Back

Apr 5, 2016 09:30AM Remedy Pharmaceuticals Appoints Dr. Thomas R. Zimmerman Jr. as Vice President, Medical Affairs

PFE and JNJ Related SEC Filings

Go Back